Novel approaches to fertility restoration in women with premature ovarian insufficiency

References

• Webber L, Davies M, Anderson R, et al. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016;31:926–37
   PubMed Web of Science ®Google Scholar
• Fraison E, Crawford G, Casper G, et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod Biomed Online 2019;39:467–76
   PubMed Web of Science ®Google Scholar
• Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an international menopause society white paper. Climacteric 2020;23:426–46
   PubMed Web of Science ®Google Scholar
• Bidet M, Bachelot A, Bissauge E, et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011;96:3864–72
   PubMed Web of Science ®Google Scholar
• Sauer MV. Spontaneous pregnancy in women awaiting oocyte donation. J Reprod Med 1995;40:630–2
   PubMed Web of Science ®Google Scholar
• Kawamura K, Cheng Y, Suzuki N, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA 2013;110:17474–9
   PubMed Web of Science ®Google Scholar
• Johnson J, Canning J, Kaneko T, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004;428:145–50
   PubMed Web of Science ®Google Scholar
• Telfer EE, Anderson RA. The existence and potential of germline stem cells in the adult mammalian ovary. Climacteric 2019;22:22–6
   PubMed Web of Science ®Google Scholar
• Attwood SW, Edel MJ. iPS-cell technology and the problem of genetic instability-can it ever be safe for clinical use? J Clin Med 2019;8:288
   Web of Science ®Google Scholar
• Pittenger MF, Discher DE, Péault BM, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med 2019;4:22
   PubMed Web of Science ®Google Scholar
• Lee HJ, Selesniemi K, Niikura Y, et al. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J Clin Oncol 2007;25:3198–204
   PubMed Web of Science ®Google Scholar
• Huang Q, Liu B, Jiang R, et al. G-CSF-mobilized peripheral blood mononuclear cells combined with platelet-rich plasma accelerate restoration of ovarian function in cyclophosphamide-induced POI rats. Biol Reprod 2019;101:91–101
   PubMed Web of Science ®Google Scholar
• Vural B, Duruksu G, Vural F, et al. Effects of VEGF + Mesenchymal Stem Cells and Platelet-Rich Plasma on Inbred Rat Ovarian Functions in Cyclophosphamide-Induced Premature Ovarian Insufficiency Model. Stem Cell Rev Rep 2019;15:558–73
   PubMed Web of Science ®Google Scholar
• Song D, Zhong Y, Qian C, et al. Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. Biomed Res Int 2016;2016:2517514
   PubMed Web of Science ®Google Scholar
• Mohamed SA, Shalaby S, Brakta S, et al. Umbilical cord blood mesenchymal stem cells as an infertility treatment for chemotherapy induced premature ovarian insufficiency. Biomedicines 2019;7:7
   Web of Science ®Google Scholar
• Ling L, Feng X, Wei T, et al. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther 2019;10:46
   PubMed Web of Science ®Google Scholar
• Elfayomy AK, Almasry SM, El-Tarhouny SA, et al. Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: possible direct and indirect effects. Tissue Cell 2016;48:370–82
   PubMed Web of Science ®Google Scholar
• Fu X, He Y, Xie C, et al. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy 2008;10:353–63
   PubMed Web of Science ®Google Scholar
• Li H, Zhao W, Wang L, et al. Human placenta-derived mesenchymal stem cells inhibit apoptosis of granulosa cells induced by IRE1α pathway in autoimmune POF mice. Cell Biol Int 2019;43:899–909
   PubMed Web of Science ®Google Scholar
• Feng P, Li P, Tan J. Human menstrual blood-derived stromal cells promote recovery of premature ovarian insufficiency via regulating the ECM-dependent FAK/AKT signaling. Stem Cell Rev Rep 2019;15:241–55
   PubMed Web of Science ®Google Scholar
• Ding C, Zhu L, Shen H, et al. Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7. Stem Cells 2020;38:1137–48
   PubMed Web of Science ®Google Scholar
• Huang B, Lu J, Ding C, et al. Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD. Stem Cell Res Ther 2018;9:216
   PubMed Web of Science ®Google Scholar
• Edessy M, Hosni H, Shady Y, et al. Autologous stem cells therapy, The first baby of idiopathic premature ovarian failure. Acta Med Int 2016;3:19–23
   Google Scholar
• Su J, Ding L, Cheng J, et al. Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency. Hum Reprod 2016;31:1075–86
   PubMed Web of Science ®Google Scholar
• Ding L, Yan G, Wang B, et al. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci 2018;61:1554–65
   PubMed Web of Science ®Google Scholar
• Terraciano P, Garcez T, Ayres L, et al. Cell therapy for chemically induced ovarian failure in mice. Stem Cells Int 2014;2014:720753
   PubMed Web of Science ®Google Scholar
• Herraiz S, Buigues A, Díaz-García C, et al. Fertility rescue and ovarian follicle growth promotion by bone marrow stem cell infusion. Fertil Steril 2018;109:908–18.e2
   PubMed Web of Science ®Google Scholar
• Cervelló I, Gil-Sanchis C, Santamaría X, et al. Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome. Fertil Steril 2015;104:1552–60.e1-3
   PubMed Web of Science ®Google Scholar
• Herraiz S, Romeu M, Buigues A, et al. Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders. Fertil Steril 2018;110:496–505.e1
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez A, Ruiz-Santiago F, García-Espinosa J. Platelet-rich plasma: myth or reality? Radiologia 2018;60:465–75
   PubMed Web of Science ®Google Scholar
• Emer J. Platelet-rich plasma (PRP): current applications in dermatology. Skin Therapy Lett 2019;24:1–6
   PubMedGoogle Scholar
• Hosseini L, Shirazi A, Naderi MM, et al. Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. Reprod Biomed Online 2017;35:343–50
   PubMed Web of Science ®Google Scholar
• Sfakianoudis K, Simopoulou M, Nitsos N, et al. Autologous platelet-rich plasma treatment enables pregnancy for a woman in premature menopause. J Clin Med 2018;8:1
   PubMed Web of Science ®Google Scholar
• Sfakianoudis K, Simopoulou M, Grigoriadis S, et al. Reactivating ovarian function through autologous platelet-rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency, perimenopausal, menopausal, and poor responder women. J Clin Med 2020;9:1809
   Web of Science ®Google Scholar
• Hsu CC, Hsu L, Hsu I, et al. Live birth in woman with premature ovarian insufficiency receiving ovarian administration of platelet-rich plasma (PRP) in combination with gonadotropin: a case report. Front Endocrinol 2020;11:50
   PubMed Web of Science ®Google Scholar
• Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 1996;11:1484–6
   PubMed Web of Science ®Google Scholar
• Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One 2010;5:e8772
   PubMed Web of Science ®Google Scholar
• Ford EA, Beckett EL, Roman SD, et al. Advances in human primordial follicle activation and premature ovarian insufficiency. Reproduction 2020;159:R15–R29
   PubMed Web of Science ®Google Scholar
• Lee HN, Chang EM. Primordial follicle activation as new treatment for primary ovarian insufficiency. Clin Exp Reprod Med 2019;46:43–9
   PubMedGoogle Scholar
• Reddy P, Liu L, Adhikari D, et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science 2008;319:611–13
   PubMed Web of Science ®Google Scholar
• Castrillon DH, Miao L, Kollipara R, et al. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 2003;301:215–18
   PubMed Web of Science ®Google Scholar
• Hosaka T, Biggs WH, 3rd, Tieu D, et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A 2004;101:2975–80
   PubMed Web of Science ®Google Scholar
• Goto M, Iwase A, Ando H, et al. PTEN and Akt expression during growth of human ovarian follicles. J Assist Reprod Genet 2007;24:541–6
   PubMed Web of Science ®Google Scholar
• McLaughlin M, Kinnell HL, Anderson RA, et al. Inhibition of phosphatase and tensin homologue (PTEN) in human ovary in vitro results in increased activation of primordial follicles but compromises development of growing follicles. Mol Hum Reprod 2014;20:736–44
   PubMed Web of Science ®Google Scholar
• Matsuda S, Nakanishi A, Wada Y, et al. Roles of PI3K/AKT/PTEN pathway as a target for pharmaceutical therapy. Open Med Chem J 2013;7:23–9
   PubMedGoogle Scholar
• Guo Y, Kwiatkowski DJ. Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis. Mol Cancer Res 2013;11:467–73
   PubMed Web of Science ®Google Scholar
• Adhikari D, Gorre N, Risal S, et al. The safe use of a PTEN inhibitor for the activation of dormant mouse primordial follicles and generation of fertilizable eggs. PLoS One 2012;7:e39034
   PubMed Web of Science ®Google Scholar
• Suzuki N, Yoshioka N, Takae S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod 2015;30:608–15
   PubMed Web of Science ®Google Scholar
• Zhai J, Yao G, Dong F, et al. In vitro activation of follicles and fresh tissue auto-transplantation in primary ovarian insufficiency patients. J Clin Endocrinol Metab 2016;101:4405–12
   PubMed Web of Science ®Google Scholar
• Lerer-Serfaty G, Samara N, Fisch B, et al. Attempted application of bioengineered/biosynthetic supporting matrices with phosphatidylinositol-trisphosphate-enhancing substances to organ culture of human primordial follicles. J Assist Reprod Genet 2013;30:1279–88
   PubMed Web of Science ®Google Scholar
• Maidarti M, Clarkson YL, McLaughlin M, et al. Inhibition of PTEN activates bovine non-growing follicles in vitro but increases DNA damage and reduces DNA repair response. Hum Reprod 2019;34:297–307
   PubMed Web of Science ®Google Scholar
• Grosbois J, Demeestere I. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation. Hum Reprod 2018;33:1705–14
   PubMed Web of Science ®Google Scholar
• Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011;13:877–83
   PubMed Web of Science ®Google Scholar
• Huang J, Reilein A, Kalderon D. Yorkie and Hedgehog independently restrict BMP production in escort cells to permit germline differentiation in the Drosophila ovary. Development 2017;144:2584–94
   PubMed Web of Science ®Google Scholar
• Polesello C, Tapon N. Salvador-warts-hippo signaling promotes Drosophila posterior follicle cell maturation downstream of notch. Curr Biol 2007;17:1864–70
   PubMed Web of Science ®Google Scholar
• Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov 2014;13:63–79
   PubMed Web of Science ®Google Scholar
• Devos M, Grosbois J, Demeestere I. Interaction between PI3K/AKT and Hippo pathways during in vitro follicular activation and response to fragmentation and chemotherapy exposure using a mouse immature ovary model. Biol Reprod 2020;102:717–29
   PubMed Web of Science ®Google Scholar
• Hu LL, Su T, Luo RC, et al. Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in mice. J Cell Physiol 2019;234:1578–87
   PubMed Web of Science ®Google Scholar
• Lunding SA, Pors SE, Kristensen SG, et al. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve. Hum Reprod 2019;34:1924–36
   PubMed Web of Science ®Google Scholar
• Fabregues F, Ferreri J, Calafell JM, et al. Pregnancy after drug-free in vitro activation of follicles and fresh tissue autotransplantation in primary ovarian insufficiency patient: a case report and literature review. J Ovarian Res 2018;11:76
   PubMed Web of Science ®Google Scholar